Ken Fisher’s SAMARITIAN PHARMACEUTICALS, INC. COM (NEW) LIV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-32,917
Closed 725
2016
Q1
$0 Hold
32,917
﹤0.01% 747
2015
Q4
$0 Hold
32,917
﹤0.01% 770
2015
Q3
$0 Hold
32,917
﹤0.01% 707
2015
Q2
$0 Hold
32,917
﹤0.01% 615
2015
Q1
$0 Hold
32,917
﹤0.01% 604
2014
Q4
$0 Hold
32,917
﹤0.01% 606
2014
Q3
$0 Hold
32,917
﹤0.01% 587
2014
Q2
$0 Hold
32,917
﹤0.01% 593
2014
Q1
$0 Hold
32,917
﹤0.01% 556
2013
Q4
$0 Hold
32,917
﹤0.01% 546
2013
Q3
$0 Hold
32,917
﹤0.01% 531
2013
Q2
$0 Buy
+32,917
New ﹤0.01% 494

Ken Fisher's LIV Position: Q2 2016 in Review

Ken Fisher sold out of SAMARITIAN PHARMACEUTICALS, INC. COM (NEW) (LIV) in Q2 2016, closing a stake of 32,917 shares.

Ken Fisher first reported a position in LIV in Q2 2013 and held it in 12 quarters. The position peaked at $0 in Q1 2016. 0 funds tracked by Wall St. Rank hold LIV as of Q2 2016.

  • Ken Fisher reported no remaining SAMARITIAN PHARMACEUTICALS, INC. COM (NEW) position as of Q2 2016 after selling out during the quarter.
  • Ken Fisher sold 32,917 SAMARITIAN PHARMACEUTICALS, INC. COM (NEW) shares in Q2 2016.
  • Ken Fisher first reported a position in SAMARITIAN PHARMACEUTICALS, INC. COM (NEW) in Q2 2013 and held it in 12 quarters.
  • Ken Fisher's SAMARITIAN PHARMACEUTICALS, INC. COM (NEW) position peaked at $0 in Q1 2016.
  • 0 funds tracked by Wall St. Rank held SAMARITIAN PHARMACEUTICALS, INC. COM (NEW) as of Q2 2016.

Based on Fisher Asset Management's 13F filing for Q2 2016, filed 12 Jul 2016.